Adult granulosa cell tumour of the ovary
Prepared with OnCo (onco.cc/prep/granulosa-cell-tumour/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
13 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example FOXL2 C134W mutation, Inhibin B and anti-Mullerian hormone, Oestradiol, Stage and rupture at surgery), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (stage i), which of the standard options do you recommend and why?
- 6.For my situation (advanced or relapsed), which of the standard options do you recommend and why?
- 7.Am I a candidate for Letrozole (and other aromatase inhibitors), Bevacizumab, Carboplatin or related drugs, and what side effects should I expect?
- 8.For my situation (follow-up), which of the standard options do you recommend and why?
- 9.Are there clinical trials I could join, for example of Bevacizumab, Letrozole (and other aromatase inhibitors)?
- 10.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 11.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
- 12.I read that “No randomised trials guide adjuvant or relapse treatment”. How does that affect my plan?
- 13.I read that “Late relapse makes follow-up long and uncertain”. How does that affect my plan?
Tests and results to bring
Biomarker results to ask for: FOXL2 C134W mutation (diagnostic), Inhibin B and anti-Mullerian hormone (monitoring), Oestradiol, Stage and rupture at surgery (prognosis).
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- Stage I: Surgical staging with hysterectomy and bilateral salpingo-oophorectomy, or unilateral oophorectomy to preserve fertility; endometrial sampling because of oestrogen exposure; no adjuvant therapy. (Ovarian cancer)
- Follow-up: Lifelong monitoring with inhibin B and imaging because relapses occur decades later. (Ovarian cancer)
- Advanced or relapsed: Repeat cytoreduction; aromatase inhibitors such as letrozole; bevacizumab; carboplatin-paclitaxel or BEP chemotherapy. (Letrozole (and other aromatase inhibitors), Bevacizumab, Carboplatin, Paclitaxel / nab-paclitaxel)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.